Portfolio company
NGeneBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops next-generation sequencing based cancer diagnostic panels and clinical analysis software for hospitals, research institutions and pharmaceutical companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GenomOncology
This company develops software platforms to analyse and interpret genomic data for molecular pathology labs, clinical oncologists and research institutions.
geninus
This company provides genomic analysis solutions and single-cell diagnostic platforms for pharmaceutical firms, healthcare providers and clinical researchers to enable precision medicine.
4BASES
This company develops diagnostic genetic testing kits and sequencing reagents for healthcare professionals and clinical laboratories to support precision medicine and disease prevention.
Fabric Genomics
This company provides a clinical software platform for genomic data interpretation and reporting to diagnostic laboratories and hospital systems.
Lunit
This company develops artificial intelligence software for medical imaging and biomarker analysis to assist hospitals and biopharmaceutical firms with cancer diagnosis and treatment.
GeneCentric
This company develops gene expression-based liquid biopsy platforms and biomarkers to help pharmaceutical and diagnostic firms identify cancer treatment responders.
NIMGenetics
The company provides genetic diagnostic services and clinical genomic tests for medical professionals in areas such as oncology, paediatrics and reproductive medicine.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
